Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australian Cervical Cancer Foundation (ACCF) is a non-profit organization dedicated to the global elimination of cervical cancer through prevention, screening, and treatment. Founded in 2008, the foundation focuses on increasing awareness and providing access to Human Papillomavirus (HPV) vaccinations and cervical screening programs, particularly in underserved communities. ACCF operates both within Australia and internationally, with significant programs in developing nations like Nepal, Bhutan, and Vietnam. The organization provides support services for women diagnosed with cervical cancer and advocates for policy changes to improve women's health outcomes. Their mission is heavily supported by Professor Ian Frazer, the co-creator of the HPV vaccine, who serves as a founding patron. The foundation's work aligns with the World Health Organization's strategy to eliminate cervical cancer as a public health problem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian Cervical Cancer Foundation.